Stock info Grifols | Filter  Basic-Info

Grifols

Grifols's headquarter is located in Barcelona. Grifols primarily operates in the pharmaceutical sector. The global pharmaceutical companies gained around 75 percent over the period 2006-2016. Measured since 2011 the sector is 147 percent higher and over the past 12 months (December 2015-2016) there is a minus of 75 percent.

The past year was a good year for Grifols investors

Over the past year the company' stock lost around 56 percent. Over the period 2011-2016 the stock rose a massive 52,25 percent. Grifols's revenues between 2011 and 2015 were very volatile through the time and moved between 2,62 billion euros and 3,93 billion euros. Grifols's net incomes between 2011 and 2015 were very volatile and moved between 50,23 million euros and 531,44 million euros.

Grifols paid out dividends in the past 5 years. Grifols's dividend return over the period 2011 - 2015 was around 0,65 percent per year.

Grifols' balance mostly financed with equity

At the end of 2015 the pharmaceutical company's balance sheet was worth 9,6 billion euros. The total debt was around 6,31 billion euros. This is 65,67 percent of the total balance sheet. At the end of 2015 the pharmaceutical company's stock was traded with a price/earnings-ratio 42. So the stock' value was 42 times the 2015' earnings per share. We could say that based on it's price/earnings-ratio and dividend yield the Spanish stock can be seen as a value stock.

At the end of 2015 the pharmaceutical company's market size (her number of outstanding share times the stock price) equaled around 29,22 billion euros. At the end of 2015 the Spanish company had around 1,37 billion stocks listed.

All Grifols's financial reports are available here. More information about Grifols can be found it's website. .